Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma

被引:40
作者
Chua, Huey-Huey [1 ]
Yeh, Te-Huei [2 ]
Wang, Ying-Piao [3 ]
Huang, Yu-Tzu [1 ]
Sheen, Tzung-Shiahn [2 ]
Lo, You-Chang [1 ]
Chou, Ya-Ching [1 ]
Tsai, Ching-Hwa [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10051, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei 10051, Taiwan
[3] Mackay Mem Hosp, Dept Otolaryngol, Taipei 10449, Taiwan
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2008年 / 30卷 / 04期
关键词
discoidin domain receptor gene family; discoidin domain receptor 2; nasopharyngeal carcinoma; Epstein-Barr virus; Z-transactivator;
D O I
10.1002/hed.20724
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
Background. Nasopharyngeal carcinoma (NPC) is associated with Epstein-Barr virus (EBV) and has high metastatic potential. Discoidin domain receptors (DDR1, DDR2) are receptor-type tyrosine kinases activated by collagen. Their ability to induce expression of matrix metal lop roteinase is related with tumor invasion. Therefore, we aim to investigate DDRs gene expression and its regulation in NPC. Methods and Results. By use of real-time quantitative polymerase chain reaction (Q-PCR), DDR2 gene expression but not DDR1 was significantly higher in primary and metastatic NPC. DDR2 was predominantly distributed in NPC tumor cells rather than in infiltrating lymphocytes. EBV Z-transactivator (Zta) transfection may distinctly elevate DDR2 level. Furthermore, data from reporter assay indicate that Zta could transactivate DDR2 promoter activity, suggesting the possible upregulation mechanism. Conclusion. DDR2 was differentially upregulated in NPC and modulated by EBV Zta protein. DDR2 may play a role in NPC invasion and serve as a diagnostic and therapeutic target. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 42 条
[1]
ALVES F, 1995, ONCOGENE, V10, P609
[2]
BARKER KT, 1995, ONCOGENE, V10, P569
[3]
Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis [J].
Burgos, JS .
MEDICAL ONCOLOGY, 2005, 22 (02) :113-121
[4]
Chalandon Y, 2005, HAEMATOLOGICA, V90, P949
[5]
Differential expression of osteoblast-specific factor 2 and polymeric immunoglobulin receptor genes in nasopharyngeal carcinoma [J].
Chang, Y ;
Lee, TC ;
Li, JC ;
Lai, TL ;
Chua, HH ;
Chen, CL ;
Doong, SL ;
Chou, CK ;
Sheen, TS ;
Tsai, CH .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (10) :873-882
[6]
The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene [J].
Chuang, TC ;
Way, TD ;
Lin, YS ;
Lee, YC ;
Law, SL ;
Kao, MC .
FEBS LETTERS, 2002, 532 (1-2) :135-142
[7]
Protein kinases as targets for anticancer agents: from inhibitors to useful drugs [J].
Fabbro, D ;
Ruetz, S ;
Buchdunger, E ;
Cowan-Jacob, SW ;
Fendrich, G ;
Liebetanz, J ;
Mestan, J ;
O'Reilly, T ;
Traxler, P ;
Chaudhuri, B ;
Fretz, H ;
Zimmermann, J ;
Meyer, T ;
Caravatti, G ;
Furet, P ;
Manley, PW .
PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) :79-98
[8]
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling - Potential implications in atherosclerosis and lymphangioleiomyomatosis [J].
Ferri, N ;
Carragher, NO ;
Raines, EW .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (05) :1575-1585
[9]
IDENTIFICATION OF PHORBOL ESTER RESPONSE ELEMENTS IN THE PROMOTER OF EPSTEIN-BARR VIRUS PUTATIVE LYTIC SWITCH GENE BZLF1 [J].
FLEMINGTON, E ;
SPECK, SH .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1217-1226
[10]
AUTOREGULATION OF EPSTEIN-BARR VIRUS PUTATIVE LYTIC SWITCH GENE BZLF1 [J].
FLEMINGTON, E ;
SPECK, SH .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1227-1232